LH vs PAHC · P/E 23, rev $13.95B vs P/E 13, rev $1.52B
Laboratory Corporation of America Holdings (LH) versus Phibro Animal Health Corporation (PAHC) — a side-by-side from cached financials, not a winner call.
Laboratory Corporation of America Holdings (LH) is a diagnostics & research company listed on US.
Phibro Animal Health Corporation (PAHC) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported LH revenue for 2025-12-31 was $13.95B. Net income was $876.5M. LH currently screens at market cap $21.07B and trailing P/E 22.8.
Latest reported PAHC revenue for 2026-06-30 was $1.52B. Net income was $99.7M. Revenue was up 17.1% from 2025-06-30 to 2026-06-30. PAHC currently screens at market cap $1.25B and trailing P/E 13.2.
LH currently screens at market cap $21.07B and trailing P/E 22.8. PAHC currently screens at market cap $1.25B and trailing P/E 13.2.
Not investment advice. Open the LH and PAHC stock pages for the full models.
Not investment advice.